Early Disease Activity or Clinical Response Predict...

  • Main
  • 2016 / 09
  • Early Disease Activity or Clinical Response Predict...

Early Disease Activity or Clinical Response Predict Long-Term Outcomes with Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis

van der Heijde, D., Deodhar, A., Fleischmann, R., Mease, P. J., Rudwaleit, M., Nurminen, T., Davies BPharm, O.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Arthritis Care & Research
DOI:
10.1002/acr.23092
Date:
September, 2016
File:
PDF, 1.27 MB
english, 2016
Conversion to is in progress
Conversion to is failed